
Infusional 5-FU, Folinic Acid, Paclitaxel, and Cisplatin for Metastatic
ByUte Klaassen, MD,Hans Jochen Wilke, MD,Christian Müller, MD,David Borquez, MD,Michael Korn, MD,Klaus Diergarten, MD,Siegfried Seeber, MD, PhD
Published: | Updated:
Our phase II study results demonstrating high efficacy and low toxicity for a weekly schedule of high-dose, 24-hour infusional 5-fluorouracil(5-FU)/folinic acid (HD5-FU/FA) in intensively pretreated patients with metastatic
